About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.
A recent American Cancer Society report highlights the increasing incidence of colorectal cancer in young adults. Understanding risk factors and recognizing symptoms are crucial for early detection ...